ClinicalTrials.Veeva

Menu

E-MOHS Trial of TENS and Vibration During Local Anesthesia

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Begins enrollment in 1 month

Conditions

Mohs Surgery
Skin Cancer
Local Anesthesia
Pain
Procedural Pain

Treatments

Device: Sham TENS
Device: Active Vibration:TENS

Study type

Interventional

Funder types

Other

Identifiers

NCT07852455
DERM-2026-35224

Details and patient eligibility

About

The E-MOHS Trial is a randomized controlled trial evaluating whether active vibration plus transcutaneous electrical nerve stimulation reduces pain during local anesthetic infiltration in adults undergoing Mohs micrographic surgery or dermatologic excision.

Participants will be randomized to active vibration:TENS or sham TENS during the first local anesthetic administration. The primary outcome is patient-reported infiltration pain during active local anesthetic infiltration, measured using the 11-point Numeric Rating Scale.

Secondary outcomes include infiltration pain measured using a Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.

Full description

Local anesthetic injection is a common source of pain and anxiety during Mohs micrographic surgery and dermatologic surgery. Physical counter-stimulation methods such as vibration and transcutaneous electrical nerve stimulation may reduce procedural pain through gate-control pain modulation.

The E-MOHS Trial is a parallel-group, two-arm, participant- and assessor-blinded randomized controlled trial. Adults undergoing Mohs micrographic surgery under local anesthesia, or dermatologic excision under local anesthesia in a pre-specified secondary population, will be enrolled on the day of surgery before the first local anesthetic administration.

Participants will be randomized 1:1 to active vibration:TENS or sham TENS. In the active arm, adhesive electrodes will be placed outside the sterile field and high-frequency transcutaneous electrical nerve stimulation will be applied during local anesthetic infiltration. A handheld vibration device will also be applied to intact skin adjacent to the injection site. In the sham arm, a fade-to-zero transient sham TENS device will be used to support blinding.

The primary endpoint is patient-reported pain of local anesthetic infiltration measured using the 11-point Numeric Rating Scale during active infiltration at the first anesthetic administration. Secondary outcomes include pain measured using a 100 mm Visual Analog Scale, perioperative anxiety, participant satisfaction, willingness to reuse the device, operator-rated ease of use and sterile-field compatibility, blinding integrity, and adverse events.

All research procedures occur during the scheduled surgical visit. No research-only follow-up visits are required. Adverse events will be monitored through the standard post-operative period as part of routine clinical care.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults 18 years of age or older scheduled for Mohs micrographic surgery under local anesthesia at a University of Minnesota or M Health Fairview dermatologic surgery clinic, or scheduled for dermatologic excision under local anesthesia as a pre-specified secondary population
  • Able to understand and rate pain on the 11-point Numeric Rating Scale and 100 mm Visual Analog Scale
  • Naive to transcutaneous electrical nerve stimulation, defined as no prior TENS exposure
  • English-speaking and able to provide informed consent in English

Exclusion criteria

  • Implanted cardiac pacemaker, implantable cardioverter-defibrillator, or other active implanted electronic device
  • Surgical site requiring electrode placement over the anterior neck or carotid sinus region
  • Pregnancy
  • Epilepsy or other seizure disorder
  • Metal implant at the intended electrode site
  • Broken, infected, eczematous, or sensory-impaired skin at the intended electrode site
  • Inability to perceive or report the stimulus, including cognitive impairment, sedation, or local neuropathy
  • Known lidocaine allergy
  • Children
  • Fetuses
  • Neonates
  • Prisoners
  • Adults lacking capacity to consent or adults with diminished or fluctuating capacity to consent
  • Non-English speakers
  • Individuals unable to read
  • Employees of the researcher
  • Students of the researcher
  • Individuals approached in emergency or acutely stressful settings

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

90 participants in 2 patient groups

Active Vibration:TENS
Experimental group
Description:
Participants will receive adjunctive high-frequency transcutaneous electrical nerve stimulation with vibratory distraction during local anesthetic infiltration for Mohs micrographic surgery or dermatologic excision.
Treatment:
Device: Active Vibration:TENS
Sham TENS
Sham Comparator group
Description:
Participants will receive sham transcutaneous electrical nerve stimulation during local anesthetic infiltration. The sham device will deliver a fade-to-zero transient current to preserve blinding.
Treatment:
Device: Sham TENS

Trial contacts and locations

3

Loading...

Central trial contact

Ian Maher, MD; Andrew Fay

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems